Oct 31, 2025
Lisa C. McClain- Amount
- Receipt pending ingestion
- Filed
- Nov 21, 2025
Congress ticker disclosure profile
As of August 22 at 12:30 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference UE. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
3
Disclosed ranges
$64K
Most active member desks
6 sells vs 5 buys
Latest trade Oct 31, 2025
Oct 31, 2025
Lisa C. McClainOct 31, 2025
Lisa C. McClainOct 30, 2025
Lisa C. McClainOct 30, 2025
Lisa C. McClainOct 30, 2025
Lisa C. McClainOct 30, 2025
Lisa C. McClainJun 17, 2025
Lisa McclainJul 12, 2023
Daniel GoldmanFeb 1, 2016
Thomas MacarthurMay 7, 2015
Thomas MacarthurMar 24, 2015
Thomas Macarthur| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Oct 31, 2025 | Lisa C. McClain | Sell | Receipt pending ingestion | Nov 21, 2025 | Receipt pending ingestion |
| Oct 31, 2025 | Lisa C. McClain | Sell | $1,001 to $15,000 | Nov 21, 2025 | Open card |
| Oct 30, 2025 | Lisa C. McClain | Sell | Receipt pending ingestion | Nov 21, 2025 | Receipt pending ingestion |
| Oct 30, 2025 | Lisa C. McClain | Buy | Receipt pending ingestion | Nov 21, 2025 | Receipt pending ingestion |
| Oct 30, 2025 | Lisa C. McClain | Sell | $1,001 to $15,000 | Nov 21, 2025 | Open card |
| Oct 30, 2025 | Lisa C. McClain | Buy | $1,001 to $15,000 | Nov 21, 2025 | Open card |
| Jun 17, 2025 | Lisa Mcclain | Buy | $1,001 to $15,000 | Aug 13, 2025 | Open card |
| Jul 12, 2023 | Daniel Goldman | Sell | $1,001 to $15,000 | Aug 13, 2023 | Open card |
| Feb 1, 2016 | Thomas Macarthur | Sell | $1,001 to $15,000 | Mar 3, 2016 | Open card |
| May 7, 2015 | Thomas Macarthur | Buy | $1,001 to $15,000 | Jun 7, 2015 | Open card |
| Mar 24, 2015 | Thomas Macarthur | Buy | $1,001 to $15,000 | Apr 11, 2015 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 8 of 11 filed rows include disclosed amount ranges (73%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.